Seminars in Nuclear Medicine
Volume 37, Issue 4 , Pages 269-285 , July 2007

Pediatric Gastrointestinal Nuclear Medicine

  • James Claude Warrington, MD, PhD
    • ,
  • Martin Charron, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Martin Charron, MD, Department of Diagnostic Imaging, Division of Nuclear Medicine, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada.

References 

  1. Treves ST, Grand RJ. Gastrointestinal bleeding. In:  Treves ST editors. Pediatric Nuclear Medicine. (ed 2). New York, NY: Springer-Verlag; 1995;p. 453–465
  2. Kumar R, Tripathi M, Chandrashekar N, et al. Diagnosis of ectopic gastric mucosa using 99mTc-pertechnetate: spectrum of scintigraphic findings. Br J Radiol. 2005;78:714–720
  3. Aiges HW. Gastrointestinal bleeding. In:  Silverberg M,  Daum F editor. Textbook of Pediatric Gastroenterology. (ed 2). Chicago: Year Book Medical Publishers; 1988;p. 137–148
  4. Maurer AH. Gastrointestinal bleeding. In:  Ell PJ,  Gambhir SS editor. Nuclear Medicine in Clinical Diagnosis and Treatment. (ed 3). Edinburgh: Churchill Livingstone; 2004;p. 911–917
  5. Alavi A, Worsley D, Zhuang H. Scintigraphic detection and localization of gastrointestinal bleeding sites. In:  Sandler MP,  Coleman RE,  Patton JA, et al. editor. Diagnostic Nuclear Medicine. (ed 4). Philadelphia, PA: Lippincott Williams and Wilkins; 2003;p. 531–551
  6. Zuckier LS. Acute Gastrointestinal bleeding. Semin Nucl Med. 2003;33:297–311
  7. Ng DA, Opelka FG, Beck DE, et al. Predictive value of Tc99m –labeled red blood cell scintigraphy for positive angiogram in massive lower gastrointestinal hemorrhage. Dis Colon Rectum. 1997;40:471–477
  8. Treves ST, Jones AG, Markisz J. Liver and spleen. In:  Treves ST editors. Pediatric Nuclear Medicine. (ed 2). New York, NY: Springer-Verlag; 1995;p. 466–495
  9. Kim CK, Norton KI, Shneider BL. Neonatal hyperbilirubinemia. In:  Ell PJ,  Gambhir SS editor. Nuclear Medicine in Clinical Diagnosis and Treatment. (ed 3). Edinburgh: Churchill Livingstone; 2004;p. 927–934
  10. McEvoy CF, Suchy FJ. Biliary tract disease in children. Pediatr Clin North Am. 1996;43:75–98
  11. Shaffer EA. Gallbladder disease. In:  Walker WA,  Durie PR,  Hamilton JR, et al. editor. Pediatric Gastrointestinal Disease. (ed 3). Hamilton, ON, Canada: B.C. Decker; 2000;p. 1291–1311
  12. Wessmann HS, Frank MS, Bernstein LH, et al. Rapid and accurate diagnosis of acute cholecystitis with 99mTc-HIDA cholescintigraphy. Am J Roentgenol. 1979;132:523–528
  13. Gilger MA. Diseases of the gallbladder. In:  Wyllie R,  Hyams JS editor. Pediatric Gastrointestinal Disease. (ed 2). Philadelphia, PA: Saunders; 1999;p. 651–662
  14. Nadel HR. Hepatobiliary scintigraphy in children. Semin Nucl Med. 1996;26:25–42
  15. Freitas JE. Cholescintigraphy. In:  Ell PJ,  Gambhir SS editor. Nuclear Medicine in Clinical Diagnosis and Treatment. (ed 3). Edinburgh: Churchill Livingstone; 2004;p. 919–926
  16. Ziessman HA, Zeman RK, Akin EA. Cholescintigraphy: correlation with other hepatobiliary imaging modalities. In:  Sandler MP,  Coleman RE,  Patton JA, et al. editor. Diagnostic Nuclear Medicine. (ed 4). Philadelphia, PA: Lippincott Williams and Wilkins; 2003;p. 503–529
  17. Malthaner RA, Newman KD, Parry R, et al. Alkaline gastroesophageal reflux in infants and children. J Pediatr Surg. 1991;26:986–991
  18. Piepsz A. Recent advances in pediatric nuclear medicine. Semin Nucl Med. 1995;25:165–182
  19. Heyman S. Gastroesophageal reflux, esophageal transit, gastric emptying, and pulmonary aspiration. In:  Treves ST editors. Pediatric Nuclear Medicine. (ed 2). New York, NY: Springer-Verlag; 1995;p. 430–452
  20. Heyman S. Pediatric gastrointestinal motility studies. Semin Nucl Med. 1995;25:339–347
  21. Heyman S. Radionuclide tranit studies. In:  Hyman PE,  Di Lorenzo C editor. Pediatric Gastrointestinal Motility Disorders. New York, NY: Academy Professional Information Services; 1994;p. 291–304
  22. Argon M, Duygun U, Daglioz G, et al. Relationship between gastric emptying and gastroesophageal reflux in infants and children. Clin Nucl Med. 2006;31:262–265
  23. Sonneville A, Ait-Tahar H, Baulieu F, et al. Value of esophageal scintigraphy in exploration of gastro-esophageal reflux in a respiratory patient. Allerg Immunol. 2000;32:207–208
  24. Demirbilek S, Karaman A, Guruluoglu K, et al. Delayed gastric emptying in gastroesophageal reflux disease: the role of malrotation. Pediatr Surg Int. 2005;21:423–427
  25. Thomas EJ, Kumar R, Dasan JB, et al. Gastroesophageal reflux in asthmatic children not responding to asthma medication: a scintigraphic study in 126 patients with correlation between scintigraphic and clinical findings of reflux. Clin Imaging. 2003;27:333–336
  26. Spiroglou K, Xinias I, Karatzas N, et al. Gastric emptying in children with cerebral palsy and gastroesophageal reflux. Pediatr Neurol. 2004;31:177–182
  27. Ozcan Z, Ozcan C, Erinc R, et al. Scintigraphy in the detection of gastro-oesophageal reflux in children with caustic oesophageal burns: a comparative study with radiography and 24-h pH monitoring. Pediatr Radiol. 2001;31:737–741
  28. Aktas A, Ciftci I, Caner B, et al. The relationship between the degree of gasto-oesophageal reflux and the rate of gastric emptying. Nucl Med Commun. 1999;20:907–910
  29. Gainey MA. Radionuclide diagnosis. In:  Walker WA,  Durie PR,  Hamilton JR, et al. editor. Pediatric Gastrointestinal Disease. (ed 3). Hamilton, ON, Canada: B.C. Decker; 2000;p. 1655–1675
  30. Klein HA. Esophageal transit scintigraphy. Semin Nucl Med. 1995;25:306–317
  31. Urbain JLC, Vekemans MM, Mamud LS. Esophageal transit, gastroesophageal reflux, and gastric emptying. In:  Sandler MP,  Coleman RE,  Patton JA, et al. editor. Diagnostic Nuclear Medicine. (ed 4). Philadelphia, PA: Lippincott Williams and Wilkins; 2003;p. 487–501
  32. Mann MD, Wynchank S. Esophageal function (transport and motility). In:  Ell PJ,  Gambhir SS editor. Nuclear Medicine in Clinical Diagnosis and Treatment. (ed 3). Edinburgh: Churchill Livingstone; 2004;p. 789–803
  33. Da-Costa-Pinto EAL, Dorsa TK, Altimani A, et al. A functional study of caustic strictures of the esophagus in children. Braz J Med Biol Res. 2004;37:1623–1630
  34. Zarate N, Mearin F, Hidalgo A, et al. Prospective evaluation of esophageal motor dysfunction in Down’s syndrome. Am J Gastroenterol. 2001;96:1718–1724
  35. Bautista A, Varela R, Villanueva A, et al. Motor function of the esophagus after caustic burn. Eur J Pediatr Surg. 1996;6:204–207
  36. Chatterton BE. Gastric motility. In:  Ell PJ,  Gambhir SS editor. Nuclear Medicine in Clinical Diagnosis and Treatment. (ed 3). Edinburgh: Churchill Livingstone; 2004;p. 805–818
  37. Avansino JR, Lorenz ML, Hendrickson ML, et al. Characterization and management of paraesophageal hernias in children after antireflux operation. J Pediatr Surg. 1999;34:1610–1614
  38. Skarsgard PL, Blair GK, Culham G. Balloon pyloroplasty in children with delayed gastric emptying. Can J Surg. 1998;41:151–155
  39. Johnson DG, Reid BS, Meyers RL, et al. Are scintiscans accurate in the selection of reflux patients for pyloroplasty?. J Pediatr Surg. 1998;33:573–579
  40. Montgomery M, Escobar-Billing R, Hellstrom PM, et al. Impaired gastric emptying in children with repaired esophageal atresia: a controlled study. J Pediatr Surg. 1998;33:476–480
  41. Dunn JC, Lai EC, Webber MM, et al. Long-term quantitative results following fundoplication and antroplasty for gastroesophageal reflux and delayed gastric emptying in children. Am J Surg. 1998;175:27–29
  42. Milla PJ. Motor disorders including pyloric stenosis. In:  Walker WA,  Durie PR,  Hamilton JR, et al. editor. Pediatric Gastrointestinal Disease. (ed 3). Hamilton, ON, Canada: B.C. Decker; 2000;p. 415–423
  43. Sýkora J, Malán A, Záhlava J, et al. Gastric emptying of solids in children with H. pylori-positive and H. pylori-negative non-ulcer dyspepsia. J Pediatr Gastroenterol Nutr. 2004;39:246–252
  44. Christian PE, Moore JG, Brown F, et al. Effect of caloric content and meal size in gastric emptying. J Nucl Med. 1982;23:P20;(abstract)
  45. Parr N, et al. The effects of pH on the distribution of radiolabels in milk—a source of error in gastric emptying tests?. Nucl Med Commun. 1986;7:298–299
  46. Signer E, Fridrich R. Gastric emptying in newborns and young infants. Acta Paediatr Scand. 1975;64:525–530
  47. Seibert JJ, Byrne WJ, Euler AR. Gastric emptying in children: unusual patterns detected by scintigraphy. Am J Roentgenol. 1983;141:49–51
  48. Savino F, Cresi F, Ferrigno M, et al. Gastric emptying in infants: epigastric impedance versus scintigraphy. Acta Paediatr. 2004;93:608–612
  49. Savino F, Ferrigno M, Cresi F, et al. Epigastric impedance and gastric scintigraphy in two infants with gastric motility disorders. J Pediatr Gastroenterol Nutr. 2001;32:S53
  50. Bekem O, Buyukgebiz B, Aydin A, et al. Prokinetic agents in children with poor appetite. Acta Gastroenterol Belg. 2005;68:416–418
  51. Sigurdsson L, Flores A, Putnam PE, et al. Postviral gastroparesis: Presentation, treatment, and outcome. J Pediatr. 1997;131:751–755
  52. Akbunar AT, Kiristioglu I, Alper E, et al. Diagnosis of orotracheal aspiration using radionuclide salivagram. Ann Nucl Med. 2003;17:415–416
  53. Baikie G, South MJ, Reddihough DS, et al. Agreement of aspiration tests using barium videofluoroscopy, salivagram, and milk scan in children with cerebral palsy. Dev Med Child Neurol. 2005;47:86–93
  54. Cook SP, Lawless S, Mandell , et al. The use of the salivagram in the evaluation of severe and chronic aspiration. Int J Pediatr Otorhinolaryngol. 1997;41:353–361
  55. Finder JD, Yellon R, Charron M. Successful management of tracheotomized patients with chronic saliva aspiration by use of constant positive airway pressure. J Pediatr. 2001;107:1343–1345
  56. Loening-Baucke VA, Younoszai MK. Abnormal anal sphincter response in chronically constipated children. J Pediatr. 1982;100:213–218
  57. Di Lorenzo C. Constipation. In:  Hyman PE,  Di Lorenzo C editor. Pediatric Gastrointestinal Motility Disorders. New York, NY: Academy Professional Information Services; 1994;p. 129–143
  58. Cook BJ, Lim E, Cook D, et al. Radionuclear transit to assess sites of delay in large bowel transit in children with chronic idiopathic constipation. J Pediatr Surg. 2005;40:478–483
  59. Shin YM, Sothwell BR, Stanton MP, et al. Signs and symptoms of slow-transit constipation versus functional retention. J Pediatr Surg. 2002;37:1762–1765
  60. Nothgi A, Hutchinson R, Kumar D, et al. Use of geometric center and parametric images in scintigraphic colonic transit studies. Gastroenterology. 1994;107:1270–1277
  61. Charles F, Camilleri M, Phillips S, et al. Scintigraphy of the whole gut: Clinical evaluation of transit disorders. Mayo Clin Proc. 1995;70:193–194
  62. Shuckett B. Cross-sectional imaging: ultrasonography, computed tomography, magnetic resonance imaging. In:  Walker WA,  Durie PR,  Hamilton JR, et al. editor. Pediatric Gastrointestinal Disease. (ed 3). Hamilton, ON, Canada: B.C. Decker; 2000;p. 1591–1660
  63. Santiago-Ribeiro M, Boddaert N, De Lonlay P, et al. Hyperinsulinism of infancy: Noninvasive differential diagnosis. In:  Charron M editors. Pediatric PET Imaging. New York, NY: Springer; 2006;p. 472–485
  64. Otonkoski T, Näntö-Slonen K, Seppänen M, et al. Nonivasive diagnosis of focal hyperinsulinism of infancy with 18F-DOPA positron emission tomography. Diabetes. 2006;55:13–18
  65. de Lonlay P, Simon-Carre A, Ribeiro M, et al. Congenital hyperinsulinism: pancreatic [18F]Fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab. 2006;91:933–940
  66. Thomson ABR, Paré P, Fedorak RN. The small intestine. In:  Thomson ABR,  Schaffer EA, et al. editor. First Principles in Gastroenterology. (ed 3). Toronto, ON, Canada: MacLean; 1997;p. 298–305
  67. leason WA. Protein-losing enteropathy. In:  Wyllie R,  Hyams JS editor. Pediatric Gastrointestinal Disease. (ed 2). Philadelphia, PA: Saunders; 1999;p. 298–305
  68. Proujansky R. Protein-losing enteropathy. In:  Walker WA,  Durie PR,  Hamilton JR, et al. editor. Pediatric Gastrointestinal Disease. (ed 3). Hamilton, ON, Canada: B.C. Decker; 2000;p. 89–102
  69. Freeman T, Gordon AH. Measurement of albumin leak into the gastrointestinal tract using 131I-albumin and ion exchange resins by mouth. Gut. 1964;6:155–157
  70. Hallaby H, Bakheeet SM, Shabib S, et al. 99mTc-Human serum albumin scans in children with protein-losing enteropathy. J Nucl Med. 2000;41:215–219
  71. Hubalewska-Hola A, Sowa-Staszczak A, Saczerbinski T, et al. Protein losing enteropathy (PLE) detected by Tc99m-labelled human serum albumin abdominal scintigraphy. Przegl Lek. 2003;60:606–608
  72. Cheung YF, Tsang HYH, Kwok JSY. Immunologic profile of patients with protein-losing enteropathy complicating congenital heart disease. Pediatr Cardiol. 2002;23:587–593
  73. Park JM, Ahn SY, Shin JI, et al. A systemic lupus erythematosus patient with protein losing enteropathy. Yonsei Med J. 2004;45:923–926
  74. Yamada M, Sumazaki R, Adachi H, et al. Resoloution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori. Eur J Pediatr. 1997;156:182–185
  75. Bhatnagar A, Kumar Singh A, Lahoti D, et al. Technetium-99m dextran: A promising new protein-losing enteropathy imaging agent. Eur J Nucl Med. 1996;23:575–578
  76. Kapoor S, Ratan SK, Kashyap R, et al. Detecting protein losing enteropathy by Tc-99m dextran scintigraphy: A novel experience. Indian J Pediatr. 2002;69:761–764
  77. Kiratli PO, Erbas B, Ozen H, et al. Tc-99m dextran scintigraphy in the diagnosis of protein losing enteropathy. Ann Nucl Med. 2001;15:153–155
  78. Carpani de Kaski M, Peters AM, Bradley D, et al. Detection and quantification of protein-losing enteropathy with indium-111 transferrin. Eur J Nucl Med. 1996;23:530–533
  79. Teisseyre M, Szymczak M, Swiatek-Rawa E, et al. Scintiscanning in diagnostics of hepatopulmonary syndrome in children. Med Sci Monit. 2001;7(suppl 1):255–261
  80. Egawa H, Kasahara M, Inomata Y, et al. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation. 1999;67:712–717
  81. Shiomi S, Iwata Y, Sasaki N, et al. Assessment of hepatic blood flow by PET with 15O water: Correlation between per-rectal portal scintigraphy with 99mTc-pertechnetate and scintigraphy with 99mTc-GSA. Nucl Med Commun. 2000;21:533–538
  82. Bohnen NI, Charron M, Reyes J, et al. Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin Nucl Med. 2000;25:447–450
  83. Szarszewski A, Korzon M, Kaminska B, et al. Duodenogastric reflux: clinical and therapeutic aspects. Arch Dis Child. 1999;81:16–20
  84. Kettner BI, Aurisch R, Ruckert JC, et al. Scintigraphic localization of lymphatic leakage site after oral administration of iodine 123-IPPA. J Nucl Med. 1998;39:2141–2144
  85. Blomquist L, Bark T, Hedenborg G, et al. Evaluation of the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Scand J Gastroenterol. 1997;32:805801
  86. Rypins B, Kipper SL. Tc-99m-hexamethylpropyleneamine (Tc-WBC) scan for diagnosing acute appendicitis in children. Am Surg. 1997;63:878–881
  87. Cheng KS, Shiau YC, Lin CC, et al. Comparison between technetium-99m hexamethylpropyleneamineoxide labeled white blood cell abdomen scan and abdominal sonography to detect appendicitis in female patients with an atypical clinical presentation. Hepatogastroenterology. 2003;50:136–139
  88. Passalaqua AM, Klein RL, Wegener WA, et al. Diagnosing suspected acute nonclassic appendicitis with sulesomab, a radiolabeled antigranuolcyte antibody imaging agent. J Pediatr Surg. 2004;39:1339–1344
  89. Rypins EB, Kipper SL, Weiland F, et al. 99mTc anti-CD 15 monoclonal antibody (Leu-Tech) imaging improves diagnostic accuracy and clinical management in patients with equivocal presentation of appendicitis. Ann Surg. 2002;235:232–239
  90. Rowland M, Bourke B, Drumm B. Gastritis and peptic ulcer disease. In:  Walker WA,  Durie PR,  Hamilton JR, et al. editor. Pediatric Gastrointestinal Disease. (ed 3). Hamilton, ON, Canada: B.C. Decker; 2000;p. 383–404
  91. Rowland M, Lambert I, Gormally S, et al. Carbon 13-labelled urea breath test for the diagnosis of Helicobacter pylori infection in children. J Pediatr. 1997;131:815–820
  92. Romagnuolo J, Schiller D, Bailey RJ. Using breath tests wisely in a gastroenterology practice and evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol. 2002;97:1113–1126
  93. Atherton JC, Spiller RC. The urea breath test for Helicobacter pylori. Gut. 1994;35:723–725
  94. Jones NL, Bourke B, Sherman PM. Breath testing for Helicobacter pylori infection in children: A breath of fresh air?. J Pediatr. 1997;131:791–793
  95. Leide-Svegborn S, Stenstrom K, Olofsson M, et al. Biokinetics and radiation doses for carbon-14 urea in adults and children undergoing the Helicobacter pylori breath test. Eur J Nucl Med. 1999;26:573–580
  96. Gunnarsson M, Leide-Svegborn S, Stenstrom K, et al. No radiation protection reasons for restrictions on 14C urea breath tests in children. Br J Radiol. 2002;75:982–986
  97. Perkins AC, Hardy JG. Intra-operative nuclear medicine in surgical practice. Nucl Med Commun. 1996;17:1006–1015
  98. Gomes P, du Boulay C, Smith CL, et al. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986;27:92–95
  99. Landi B, Anh TN, Cortot A, et al. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives Endoscopic monitoring of Crohn’s disease treatment: A prospective, randomized clinical trial. Gastroenterology. 1992;102:1647–1653
  100. Pera A, Bellando P, Caldera D, et al. Colonoscopy in inflammatory bowel disease (Diagnostic accuracy and proposal of an endoscopic score). Gastroenterology. 1987;92:181–185
  101. Daum F, Markowitz J, Rosa J, et al. Does proctosigmoiditis in inflammatory bowel disease presage the imminent onset of symptoms?. J Pediatr Gastroenterol Nutr. 1989;8:339–342
  102. Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn’s disease (Evolution on prednisolone). Groupe d’Etude Therapeutique des Affections Inflammatoires Digestives Gastroenterology. 1990;98:811–818
  103. Modigliani R. Endoscopic severity index for Crohn’s disease. Gastrointest Endosc. 1990;36:637
  104. Kirschner BS. Ulcerative colitis and Crohn’s disease in children (Diagnosis and management). Gastroenterol Clin North Am. 1995;24:99–117
  105. Nelson RL, Schwartz A, Pavel D. Assessment of the usefulness of a diagnostic test: A survey of patient preference for diagnostic techniques in the evaluation of intestinal inflammation. BMC Med Res Methodol. 2001;1:5
  106. Ekberg O, Fork FT, Hildell J. Predictive value of small bowel radiography for recurrent Crohn Disease. Am J Roentgenol. 1980;135:1051–1055
  107. Macfarlane PI, Miller V, Ratcliffe JF. Clinical and radiological diagnosis of Crohn’s disease in children. J Pediatr Gastroenterol Nutr. 1986;5:87–92
  108. Kjeldsen J, Schaffalitzky de Muckadell OB. Assessment of disease severity and activity in inflammatory bowel disease. Scand J Gastroenterol. 1993;28:1–9
  109. Charron M, Di Lorenzo C, Kocoshis S. CT and 99mTc-WBC vs colonoscopy in the evaluation of inflammation and complications of inflammatory bowel diseases. J Gastroenterol. 2002;37:23–28
  110. Shields RA, Lawson RS. Effective dose equivalent. Nucl Med Commun. 1987;8:851–855
  111. Charron M, Di Lorenzo C, Kocoshis SA. Are 99nTc leukocyte scintigraphy and SBFT studies useful in children suspected of having inflammatory bowel disease?. Am J Gastroenterol. 2000;95:1208–1212
  112. Charron M, Orenstein SR, Bhargava S. Detection of inflammatory bowel disease in pediatric patients with technetium-99m-HMPAO-labeled leukocytes. J Nucl Med. 1994;35:451–455
  113. Charron M, Del Rosario JF, Kocoshis S. Pediatric inflammatory bowel disease: Assessment with scintigraphy with 99mTc white blood cells. Radiology. 1999;212:507–513
  114. Wallis JW, Miller TR. Volume rendering in three-dimensional display of SPECT images. [see comments] J Nucl Med. 1990;31:1421–1428
  115. Kipper S. Radiolabeled leukocyte imaging of the abdomen. In:  Freeman L editors. Nuclear Medicine Annual. New York, NY: Raven Press; 1995;p. 81–128
  116. Roddie ME, Peters AM, Danpure HJ, et al. Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. Radiology. 1988;166:767–772
  117. Lantto EH, Lantto TJ, Vorne M. Fast diagnosis of abdominal infections and inflammations with technetium-99m-HMPAO labeled leukocytes. J Nucl Med. 1991;32:2029–2034
  118. Charron M, Del Rosario JF, Kocoshis S. Comparison of the sensitivity of early versus delayed imaging with Tc-99m HMPAO WBC in children with inflammatory bowel disease. Clin Nucl Med. 1998;23:649–653
  119. Hotze A, Briele B, Wolf F, et al. Localization and activity of inflammatory bowel disease using 111In leukocyte imaging. Nuklearmedizin. 1988;27:83–86
  120. Peters AM, Roddie ME, Danpure HJ, et al. Tc99m-HMPAO labelled leucocytes: Comparison with 111In-tropolonate labelled granulocytes. Nucl Med Commun. 1988;9:449–463
  121. Vilien M, Nielsen SL, Jorgensen M, et al. Leucocyte scintigraphy to localize inflammatory activity in ulcerative colitis and Crohn’s disease. Scand J Gastroenterol. 1992;27:582–586
  122. Kennan N, Hayward M. Tc HMPAO-labelled white cell scintigraphy in Crohn’s disease of the small bowel. Clin Radiol. 1992;45:331–334
  123. Li DJ, Middleton SJ, Wraight EP. 99mTc and 111In leucocyte scintigraphy in inflammatory bowel disease. Nucl Med Commun. 1992;13:867–870
  124. Arndt JW, van der Sluys Veer A, Blok D, et al. Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease. J Nucl Med. 1993;34:1052–1057
  125. Laitinen R, Tahtinen J, Lantto T, et al. Tc-99m labeled leukocytes in imaging of patients with suspected acute abdominal inflammation. Clin Nucl Med. 1990;15:597–602
  126. Charron M, del Rosario JF, Kocoshis SA. Characterization of late abdominal accumulation of 99Tcm-HMPAO leukocytes in a large population of children. Nucl Med Commun. 1998;19:753–759
  127. Davidson J, Poon FW, Bessent RG, et al. Pethidine-augmented white cell scintigraphy in inflammatory bolwel disease. Eur J Nucl Med. 2000;27:656–659
  128. Charron M. Temporal correlation of the erythrocyte sedimentation rate with Tc-99m WBC uptake on children with inflammatory bowel diseases. Clin Nucl Med. 2003;28:905–907
  129. Charron M. Inflammatory bowel disease activity assessment with biologic markers and 99mTc-WBC scintigraphy: Are there different trends in ileitis versus colitis?. J Nucl Med. 2003;44:1586–1591
  130. Peacock K, Porn U, Howman-Giles R, et al. 99mTc-stannous colloid white cell scintigraphy in childhood inflammatory bowel disease. J Nucl Med. 2004;45:261–265
  131. Bruno I, Martelossi S, Geatti O, et al. Antigranulocyte monoclonal antibody immunoscintigraphy in inflammatory bowel disease in children and young adolescents. Acta Paediatr. 2002;91:1050–1055
  132. Charron M, Di Lorenzo C, Kocoshis SA, et al. 99mTc antigranulocyte monoclonal antibody imaging for the detection and assessment of inflammatory bowel disease newly diagnosed by colonoscopy in children. Pediatr Radiol. 2001;31:796–800
  133. Skehan SJ, Issenman R, Mernagh J, et al. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet. 1999;354:836–837
  134. Lemberg DA, Issenman RM, Cawdron R, et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:733–738
  135. Arndt JW, Grootscholten MI, van Hogezand RA, et al. Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes. Dig Dis Sci. 1997;42:387–393
  136. Giaffer MH, Tindale WB, Holdsworth D. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1996;8:1195–1200
  137. Gibson P, Lichtenstein M, Salehi N, et al. Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation. Gut. 1991;32:1502–1507
  138. Charron M, Fernando del Rosario J, Kocoshis S. Distribution of acute bowel inflammation determined by technetium-labeled white blood cells in children with inflammatory bowel disease. Inflamm Bowel Dis. 1998;4:84–88
  139. Sciarretta G, Furno A, Mazzoni M, et al. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn’s disease: diagnostic and clinical relevance. (see comments) Gut. 1993;34:1364–1369
  140. Jobling JC, Lindley KJ, Yousef Y, et al. Investigating inflammatory bowel disease—white cell scanning, radiology, and colonoscopy. Arch Dis Child. 1996;74:22–26
  141. Papos M, Nagy F, Lang J, et al. Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn’s disease. Eur J Nucl Med. 1993;20:766–769
  142. Reynolds JH, Graham D, Smith FW. Imaging inflammation with 99mTc HMPAO labelled leucocytes. Clin Radiol. 1990;42:195–198
  143. Middleton SJ, Li D, Wharton S, et al. Validation of 99Tcm-HMPAO leucocyte scintigraphy in ulcerative colitis by comparison with histology. Br J Radiol. 1995;68:1061–1066
  144. Allan RA, Sladen GE, Bassingham S, et al. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease. Eur J Nucl Med. 1993;20:195–200
  145. Becker W, Schomann E, Fischbach W, et al. Comparison of 99Tcm-HMPAO and 111In-oxine labelled granulocytes in man: First clinical results. Nucl Med Commun. 1988;9:435–447
  146. Spinelli F, Milella M, Sara R, et al. The 99mTc-HMPAO leukocyte scan: An alternative to radiology and endoscopy in evaluating the extent and the activity of inflammatory bowel disease. J Nucl Biol Med. 1991;35:82–87
  147. Giaffer MH. Labelled leucocyte scintigraphy in inflammatory bowel disease: Clinical applications. Gut. 1996;38:1–5
  148. Alberini JL, Badran A, Freneaux E, et al. Technetium-99m HMPAO-labeled leukocyte imaging compared with endoscopy, ultrasonography, and contrast radiology in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;32:278–286
  149. Charron M, Del Rosario F, Kocoshis S. Assessment of terminal ileal and colonic inflammation in Crohn’s disease with 99mTc-WBC. Acta Paediatr. 1999;88:193–198
  150. Morelec I, Nancey S, Roman S, et al. Is scintigraphic double-track appearance a sign of severe acute episodes of ulcerative colitis?. Gastroenterol Clin Biol. 2004;28:221–225
  151. Almers S, Granerus G, Franzen L, et al. Technetium-99m scintigraphy: More accurate assessment of ulcerative colitis with exametazime-labelled leucocytes than with antigranulocyte antibodies. Eur J Nucl Med. 1996;23:247–255
  152. Lewis GW, Mansberg R, Howman-Giles R. Rectal Crohn’s disease on labeled leukocyte scintigraphy. Clin Nucl Med. 1999;24:363–364
  153. Biancone L, Scopinaro F, Ierardi M, et al. 99mTc-HMPAO granulocyte scintigraphy in the early detection of postoperative asymptomatic recurrence in Crohn’s disease. Dig Dis Sci. 1997;42:1549–1556
  154. Rispo A, Imbriaco M, Celentano L, et al. Noninvasive diagnosis of small bowel Crohn’s disease: Combined use of bowel sonography and 99mTc-HMPAO leukocyte scintigraphy. Inflamm Bowel Dis. 2005;11:376–382
  155. Bhargava SA, Orenstein SR, Charron M. Technetium-99m hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease in children. J Pediatr. 1994;125:213–217
  156. Olaison G, Smedh K, Sjodahl R. Natural course of Crohn’s disease after ileocolic resection: endoscopically visualized ileal ulcers preceding symptoms. Gut. 1992;33:331–335
  157. Papos M, Varkonyi A, Lang J, et al. HM-PAO-labeled leukocyte scintigraphy in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1996;23:547–552
  158. Charron M. Inflammatory Bowel Disease in Pediatric Patients. Q J Nucl Med. 1997;4:309–320

PII: S0001-2998(07)00026-8

doi: 10.1053/j.semnuclmed.2007.02.005

Seminars in Nuclear Medicine
Volume 37, Issue 4 , Pages 269-285 , July 2007

Article Tools

* Image Usage & Resolution